Friday Nov 27 | Tech Confidential Blog
In the decade that Miles White has headed Abbott Laboratories , the healthcare and pharmaceuticals giant has done more than $30 billion worth of deals, greatly expanding its offering of drugs, nutritional products, medical devices and diagnostic equipment.
Chasing Value: Ten stocks for 2010 -- Part 5
Filed under: Microsoft , Abbott Laboratories , Chasing Value , Stocks to Buy The march toward year end continues as three more stocks are reviewed in a search for the eventual 2010 stock picks.
Abbott's diet drug's risks have FDA's attention
"The analysis of these data is ongoing and FDA is making no conclusions about the preliminary findings at this time," the agency said in a statement.
Abbott Laboratories Reports Positive Results on Niaspan
Abbott Laboratories announced on Monday positive results of cholesterol drug Niaspan.
Abbott's Niaspan Works Better Than Merck's Zetia in Artery Clearing Study
A finding that Merck & Co.a s cholesterol pills Vytorin and Zetia didna t reopen clogged arteries as well as Abbott Laboratories a Niaspan has set off a medical debate on heart treatment strategies.
Abbott Labs Is Making the Right Moves
Wedbush Pac Grow initiated coverage of the health-care firm at Outperform. Abbott Laboratories By Wedbush Pac Grow Life Sciences WE ARE INITIATING COVERAGE of Abbott Laboratories with an Outperform rating.
Abbott under kickback probe over Depakote sales
Abbott Laboratories this morning confirmed the company's sales and marketing practices of Depakote, the widely used drug to treat bipolar disorder and epilepsy, are under federal investigation.
Abbott's $1.67 Billion Patent-Suit Loss to J&J Over Humira Upheld By Judge
Abbott Laboratories failed to convince a federal judge to throw out a record $1.67 billion verdict won by Johnson & Johnsona s Centocor unit in a suit over an arthritis drug patent.
Crain's Chicago Business Weekly Edition
29 | Founder, CEO | Groupon Inc. | Chicago For someone with a life goal no less lofty than "changing the world," Andrew Mason doesn't seem to take himself too seriously. When he found out that his company, Groupon, was up against Abbott Laboratories for a Chicago Innovation people's choice award, ...
Scam victims left to pick up pieces after losing everything
In 2001, Lillie Greene's life was turned upside down. Her son, not knowing he was diabetic, suffered an aneurysm and went into a coma for 32 days.
Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
Abbott Park, Illinois - Abbott announced today that it has received the annual Illinois Continuous Improvement Award for environmental excellence.
Impax Laboratories initiates patent challenge for TRICOR
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICORA tablets, 48 mg and 145 mg.
Jensen Fund Bets on Abbott, Adobe
Rob McIver, co-manager of the Jensen Fund , says long-term investing success means selecting high-quality securities, such as Abbott Laboratories and Adobe .
Abbott opens new R&D center at U of I
Abbott Laboratories has opened its Abbott Nutrition facility at the Research Park on the University of Illinois campus.
SADIF Analytics releases new summary due diligence report for Abbott Laboratories
Ilhavo, Portugal a ' 20/10/2009 a ' SADIF Investment Analytics, announces a new summary due diligence report covering Abbott Laboratories .
Baxter and Abbott Refuse to Be Toppled by Foreign Currency Headwinds, an Industrial Info News Alert
Global pharmaceutical companies Baxter International Incorporated : and Abbott Laboratories : this week reported earnings for the third quarter of their 2009 fiscal years.
Abbott Laboratories said third quarter earnings surged by more than a third, to $1.48 billion, or 95 cents per share.
Abbott Laboratories led drug stocks into positive territory Wednesday, as shares of the conglomerate gained in the wake of a better-than-expected third-quarter earnings report.
Abbott Labs profit tops forecasts on greater Humira sales, raises 2009 profit view
Abbott Laboratories says it beat its own expectations in the third quarter as sales of its drug Humira continued to climb, as did sales of medical products and nutritional products for children.
Before the Bell: J.P. Morgan, Intel, Abbott Laboratories in focus
A surprisingly strong profit and outlook from Intel and much stronger-than-forecast results from J.P. Morgan Chase sent U.S. stock futures rallying Wednesday and put a 10,000 level on the Dow Jones Industrial Average within reach.
Also on Topix